Umbilical Cord Blood NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Umbilical Cord Blood NK Cells, covering 2023-02-16 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 2]